Type
1.
Bardosh K Center for One Health Research, School of Public Health, University of Washington, Seattle, WA 98195, USA, Jean L, Beau De Rochars V, Lemoine J, Okech B, Ryan S, et al. Polisye Kont Moustik: A culturally competent approach to larval source reduction in the context of lymphatic filariasis and malaria elimination in Haiti. Tropical medicine and infectious disease [Internet]. 2017;2(3):39. Available from: http://www.mdpi.com/2414-6366/2/3/39/pdf
Type
1.
Chaudhary S, Kubde S, Khamgaonkar M. Progress towards elimination of lymphatic filariasis in two districts of Maharashtra: scenario of last five years. International journal of community medicine and public health [Internet]. 2017;4(9):3230-3. Available from: http://www.ijcmph.com/index.php/ijcmph/article/viewFile/1265/1404
Type
1.
Nsakashalo-Senkwe, Mwase, Chizema-Kawesha, Mukonka, Songolo, Masaninga, et al. Significant decline in lymphatic filariasis associated with nationwide scale-up of insecticide treated nets in Zambia. Parasite epidemiology and control [Internet]. 2017; Available from: http://tinyurl.com/y7efmb55
Type
1.
Hettrick. Establishing a lymphatic filariasis morbidity plan for Haiti. Wound practice and research [Internet]. 2017;25(3):146-8. Available from: http://www.woundsaustralia.com.au/journal/2503_05.pdf
Type
1.
Streit T, Lafontant JG, Direny A, Addiss D, Milord MD 8Health and Development International, Newburyport, Massachusetts;, Lammie P, et al. Translating research into reality: Elimination of lymphatic filariasis from Haiti. The American journal of tropical medicine and hygiene [Internet]. 2017;97(4_Suppl):71–75. Available from: http://www.ajtmh.org/docserver/fulltext/14761645/97/4_Suppl/tpmd160669.pdf?expires=1508839073&id=id&accname=guest&checksum=5B58BDFAE9F5311FA5E72B7F88FB6E0B
Type
1.
Horstick O, Runge-Ranzinger S. Protection of the house against Chagas disease, dengue, leishmaniasis, and lymphatic filariasis: a systematic review. The Lancet. Infectious diseases. 2017;
Type
1.
Koroma. Preventive chemotherapy for elimination of lymphatic filariasis and onchocerciasis in Sierra Leone. Vol. Doctoral, University of Liverpool . 2017.
Type
1.
World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2016. Weekly epidemiological record [Internet]. 2017;92(40):594-608. Available from: http://apps.who.int/iris/bitstream/10665/259184/1/WER9240.pdf?ua=1
Type
1.
Shrivastava S, Shrivastava P, Ramasamy J. Elimination target for lymphatic filariasis attained in Sri Lanka and Maldives: World health organization. Annals of tropical medicine and public health [Internet]. 2017;10(5):1369-70. Available from: http://www.atmph.org/article.asp?issn=1755-6783;year=2017;volume=10;issue=5;spage=1369;epage=1370;aulast=Shrivastava
Type
1.
Pam D, Souza D, D’Souza S, Opoku M, Sanda S, Nazaradden I, et al. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria. PLoS neglected tropical diseases [Internet]. 2017;11(10):e0006004. Available from: http://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0006004&type=printable